NDC 51672-4045-01 - Enalapril Maleate and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-4045
- Requested NDC
- 51672-4045-01
- Package NDCs from labels
- 51672-4045-1, 51672-4045-3, 51672-4045-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries, Ltd.
- Effective date
- 2026-07-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Enalapril Maleate and Hydrochlorothiazide Tablets, USP | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries, Ltd. | 2026-07-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4045-1 | Enalapril Maleate and Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET | 100 | 12 | |
| 51672-4045-3 | Enalapril Maleate and Hydrochlorothiazide | 1000 in 1 BOTTLE | TABLET | 1000 | 12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4045 | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE TABLET [TARO PHARMACEUTICALS U.S.A., INC.] | 12 | Current NDC, Legacy NDC, 2 package rows | 20240509_7cb92cf2-46f2-4379-937c-168d230e43a4.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-4045-1 | EA - Each | 51672-4045 | 65069710-3c5b-4339-ba87-09ceb26cf720 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | ScieGen Pharmaceuticals, Inc. | 02e96a51-1d56-460c-8c20-3d6f37e0ce46 | 2020-05-11 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Actavis Pharma, Inc. | ab5e9ae4-e575-4a63-99f3-2bde36bdd508 | 2020-05-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Enalapril Maleate | ENALAPRIL MALEATE | Proficient Rx LP | ca1d0143-bbd3-4041-9981-eadbb8893a2b | 2020-03-01 | Boxed warning, Warnings, Adverse reactions | 9O25354EPJ |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Aphena Pharma Solutions - Tennessee, LLC | e2903227-4a79-4a9c-b96b-073b8e41fb01 | 2020-01-13 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Sterile Water | WATER | Baxter Healthcare Company | 8bcf5572-49e1-4302-9522-56f57904cb4a | 2019-12-29 | Warnings, Adverse reactions | 059QF0KO0R |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | 33710c3c-6f17-457a-8665-04c23bca8b75 | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | a06ee3c1-bd0d-4dda-a453-1655eebffdae | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | 411caa05-5eff-4285-a940-7f6d2429ba81 | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | e1f94546-c71c-4175-9384-20238181e05f | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | c5f26357-40f3-49f4-99f2-845a8dda5f39 | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | 1f6ab5e0-8320-4489-bed2-8c90c534e5ae | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | be008c6a-6036-4abf-a3fc-450465c88d55 | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Enalapril Maleate | ENALAPRIL MALEATE | Proficient Rx LP | cc921315-8da1-487c-ba19-433470f5c8d8 | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | 9O25354EPJ |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | ec24af8d-29a3-4217-8f06-ac217ea55b9e | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | 6c363351-6596-42bf-83c9-041bf231b778 | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Aphena Pharma Solutions - Tennessee, LLC | 5eea66bd-589a-45f8-ba2c-dea66a939d59 | 2019-05-13 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Enalapril Maleate | ENALAPRIL | Amneal Pharmaceuticals NY LLC | e81a8aca-0e7c-4a02-b596-09e4ac22c70e | 2019-03-29 | Boxed warning, Warnings, Adverse reactions | 9O25354EPJ |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Zydus Pharmaceuticals (USA) Inc. | ee11db7b-91bd-4231-8783-889d98e4fa32 | 2019-02-23 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Amneal Pharmaceuticals LLC | c9acbc95-3629-4276-842b-5c074844dba7 | 2019-02-02 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Exelan Pharmaceuticals Inc. | b5a1b38c-0433-4649-a8b0-f72db0a96c45 | 2018-12-28 | Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.